Table 1.

Comparison of sequenced personal human genomes

Individual	Ploidy	Technology	Av Depth	Total SNPs [M]	Known SNPs [M] (%)	Novel SNPs [M] (%)	Heterozygous SNPs [M] (%)	Homozygous SNPs [M] (%)	cSNPs	nsSNPs	InDels	CNVs (≥100 bp)
Venter	2n	Sanger	7.5×	3.21	2.80 (87.22%)	0.41 (12.77%)	1.76 (54.85%)	1.45 (45.15%)	21,152	6,114	214,691	6,485
Watson	2n	Roche 454	7.4×	3.32	2.71 (81.73%)	0.61 (18.27%)	1.67 (50.53%)	1.64 (49.47%)	22,041	10,659	222,718	1,674
Chinese (YH)	2n	Illumina	36.0×	3.07	2.65 (87.13%)	0.41 (12.87%)	1.72 (56.03%)	1.35 (43.97%)	15,759	7,062	135,262	2,682
African (NA18507)*	2n	Illumina	40.6×	3.61	2.72 (75.50%)	0.88 (24.50%)	2.28 (63.21%)	1.32 (36.79%)	26,140	5,361	404,416	8,470
African (NA18507)*	2n	AB SOLiD	17.9×	3.86	3.13 (81.00%)	0.73 (19.00%)	2.33 (60.30%)	1.53 (39.70%)	68,624	9,902	226,529	6,714
Korean (SJK)	2n	Illumina	28.9×	3.43	3.01 (87.79%)	0.42 (12.21%)	2.00 (58.21%)	1.43 (41.79%)	27,118	9,334	342,965	3,303
Korean (AK1)	2n	Illumina	27.8×	3.45	2.86 (83.30%)	0.59 (16.70%)	2.11 (61.11%)	1.34 (38.89%)	21,606	10,162	170,202	414
Khoisan (KB1)	2n	Roche 454	10.2×	4.05	3.31 (81.65%)	0.74 (18.35%)	2.39 (59.00%)	1.66 (41.00%)	22,119	na	463,788	na
D. Tutu (ABT)	2n	AB SOLiD	30.0×	3.62	3.21 (88.61%)	0.41 (11.39%)	2.17 (60.00%)	1.44 (40.00%)	17,342	na	3,395	na
Lupski	2n	AB SOLiD	29.6×	3.42	2.85 (83.58%)	0.56 (16.42%)	2.00 (58.72%)	1.41 (41.28%)	18,406	9,069	na	530

^*Same HapMap sample was independently sequenced and reported using two different technologies.

Abbreviations: cSNPs, coding SNPs; nsSNPs, nonsynonymous SNPs; CNVs, copy-number variants; na, data not available.